Part 1 - Informed Consent - The First and Most Important Element of a Clinical Trial
6 dic 2023 ·
39 min. 4 sec.
![Part 1 - Informed Consent - The First and Most Important Element of a Clinical Trial](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/2b6079f1a28350721c55dcc9131f0edd.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
This is the first in a series of podcasts specifically dedicated to how good clinical research on pharmaceutical products is planned, conducted, analyzed and approved. Given the recent Plandemic and...
mostra di più
This is the first in a series of podcasts specifically dedicated to how good clinical research on pharmaceutical products is planned, conducted, analyzed and approved. Given the recent Plandemic and Covid-19 "vaccine" rollout including mandates for people to either get vaxed or lose their jobs, livelihoods, and in some cases, their families, I wanted to created a series that would educate people on the process of clinical research - how a new drug gets to market, so that they could make more informed decisions about what they will and will not choose to put in their bodies. Informed Consent is the first and most important part of the process given that patients were basically put in a drug study without their informed consent if they took the Covid-19 "vaccine". Episode 1 is on Informed Consent in Clinical Research.
Book a Complementary Solution Session so you can find out how to go from Pharma to Dharma and learn how to reduce or eliminate the need for toxic pharmaceuticals! https://vedicalchemy.org/pharma-to-dharma
mostra meno
Book a Complementary Solution Session so you can find out how to go from Pharma to Dharma and learn how to reduce or eliminate the need for toxic pharmaceuticals! https://vedicalchemy.org/pharma-to-dharma
Informazioni
Autore | Amazing Women and Men Of Power |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company